BioBridge Global announces appointment of John Youngdahl as Chief Financial Officer
July 6, 2022
Youngdahl to replace retiring Glenn Kues
Youngdahl to replace retiring Glenn Kues
Adrienne has taken on multiple challenges throughout her career, stretching her capabilities and her knowledge of her interests while thinking of herself a lifelong learner and adventurer.
Surprise guests, heartfelt thanks and a really big card helped the organization commemorate the retirement of Elizabeth Waltman.
Rigorous review process leads to accreditation for peripheral blood collection under high quality care for patients
During the recent send-off event for Elizabeth Waltman, she received a special honor: The THOR sword.
Center for Advanced Therapies is part of the ever-expanding field of cellular and immune therapies, assisting with various phases of research into therapies to cure chronic, debilitating and degenerative diseases.
Stem cells from cord tissue to be used to develop new cellular therapies
Helipad will resupply blood for emergency medical providers and aid in major trauma care.
The South Texas Blood & Tissue Center is helping to launch a first-in-the nation partnership to ensure blood will be available in mass trauma situations and natural disasters.
Partnership to develop new cryopreservation systems for the advancement of human blood services and advanced cellular therapies
From new assays to new ways of looking at donations, BBG R&D is making an impact.
This whitepaper goes through five testing strategies that QualTex Laboratories use to help customers in the cell and cell-based therapy industry.
